China Hemodialysis & Peritoneal Dialysis Market

The China hemodialysis and peritoneal dialysis market is experiencing rapid expansion, driven by a sharp rise in chronic kidney disease (CKD) and end-stage renal disease (ESRD) cases across the country. Valued at USD 7.85 billion in 2025, the market is projected to grow at a strong CAGR of 9.30% from 2026 to 2035, reaching approximately USD 19.10 billion by 2035.

China’s large population base, aging demographics, and increasing prevalence of diabetes and hypertension continue to place significant pressure on renal healthcare infrastructure. Dialysis therapies hemodialysis and peritoneal dialysis remain critical, life-sustaining treatments, making this market a key pillar of the country’s medical device and healthcare services landscape.

Key Growth Drivers of the China Dialysis Market

Rising Burden of End-Stage Renal Disease

The primary growth driver of the China hemodialysis and peritoneal dialysis market is the rapid increase in ESRD cases. Lifestyle changes, urbanization, poor dietary habits, and growing rates of diabetes and hypertension are accelerating kidney disease incidence, significantly expanding the dialysis patient pool.

Expanding Healthcare Infrastructure and Government Support

China has made substantial investments in healthcare infrastructure development, particularly in secondary and tertiary hospitals. Government initiatives aimed at expanding insurance coverage and improving access to renal care have increased patient affordability, driving higher dialysis treatment adoption across urban and semi-urban regions.

Growing Adoption of Home Dialysis

The market is witnessing a gradual shift toward home-based dialysis, especially peritoneal dialysis. This trend is driven by cost-effectiveness, convenience, reduced hospital burden, and improved quality of life for patients. Technological improvements in dialysis equipment and patient training programs are further supporting adoption.

Get a Free Sample Report with Table of Contents:

Technological Advancements in Dialysis Equipment

Continuous innovation in dialysis machines, membranes, and monitoring systems is improving treatment efficiency and patient safety. Advanced high-flux dialyzers, automated peritoneal dialysis systems, and digital patient management solutions are enhancing clinical outcomes and strengthening market growth.

Market Segmentation Insights

By Type

• Hemodialysis dominates the market due to its widespread availability in hospitals and dialysis centers and its suitability for critical ESRD patients.
• Peritoneal Dialysis is growing at a faster rate, driven by home-care preferences and government initiatives encouraging its use to reduce in-center treatment burden.

By Product and Services

• Equipment includes dialysis machines and water treatment systems, forming a significant portion of capital expenditure.
• Consumables, such as dialyzers, tubing, and solutions, represent the largest recurring revenue segment.
• Drugs support dialysis therapy through anemia and mineral balance management.
• Services include dialysis treatment administration and patient care, growing alongside the expanding dialysis network.

By Dialysis Site

• In-center dialysis remains dominant due to clinical supervision and infrastructure availability.
• Home dialysis is gaining momentum, particularly in urban regions, supported by improved patient education and reimbursement policies.

Regional Market Analysis

Eastern and coastal regions of China, including major metropolitan areas, account for the largest share of the dialysis market due to superior healthcare facilities and higher diagnosis rates. Central and western regions present strong growth potential as healthcare access improves and government investment continues to expand renal care services in underserved areas.

Key Challenges Facing the Market

High Treatment and Operational Costs

Despite expanding insurance coverage, dialysis remains cost-intensive, especially for long-term patients. Equipment procurement, consumables, and trained personnel requirements place financial strain on both providers and patients.

Uneven Access to Dialysis Services

Significant regional disparities persist in dialysis access, particularly between urban and rural areas. Limited infrastructure and skilled professionals in less-developed regions restrict market penetration.

Workforce and Training Constraints

The growing dialysis patient population requires skilled nephrologists, nurses, and technicians. Shortages in trained healthcare personnel can impact service quality and limit capacity expansion.

Infection Risk and Clinical Complications

Dialysis procedures carry risks of infection and other complications, increasing the burden on healthcare providers to maintain strict quality and safety standards.

Competitive Landscape

The China hemodialysis and peritoneal dialysis market features a mix of international and domestic players focused on expanding local production, partnerships, and service networks. Key companies include:

• Asahi Kasei Medical Co., Ltd.
• Shandong Weigao Group Medical Polymer Company Limited
• Shenzhen Landwind Industry Co., Ltd.
• Baxter International Inc.

These players compete through technology innovation, pricing strategies, localization, and comprehensive service offerings.